Interaction of a Novel Alternatively Spliced Variant of <i>HSD11B1L</i> with Parkin Enhances the Carcinogenesis Potential of Glioblastoma: Peiminine Interferes with This Interaction
Glioblastoma (GBM) is a primary brain tumor of unknown etiology. It is extremely aggressive, incurable and has a short average survival time for patients. Therefore, understanding the precise molecular mechanisms of this diseases is essential to establish effective treatments. In this study, we clon...
Main Authors: | Ru-Huei Fu, Syuan-Yu Hong, Chia-Wen Tsai, Shih-Ping Liu, Shao-Chih Chiu, Meng-Zhen Wu, Woei-Cherng Shyu, Shinn-Zong Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/6/894 |
Similar Items
-
Progress on the role of 11β-HSD1 in inflammation,development of hepatocellular carcinoma and immunity
by: LEI Xingyu, FENG Xuesong, CHAO Xu
Published: (2023-05-01) -
11β-HSD1 participates in epileptogenesis and the associated cognitive impairment by inhibiting apoptosis in mice
by: Xueying Li, et al.
Published: (2022-09-01) -
A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome
by: Yoon-Ju Na, et al.
Published: (2020-05-01) -
Glucocorticosteroids – a new target in the treatment of metabolic syndrome
by: Szymon Baumgart, et al.
Published: (2024-04-01) -
11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway
by: Ying Chen, et al.
Published: (2022-06-01)